The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
What Are The Respective Roles Of The Public And Private Sectors In Pharmaceutical Innovation?
Abstract
What are the respective roles of the public and private sectors in drug development? This question is at the heart of some policy proposals, such as those that would give the government a share of profits from drugs at least partly developed with federal research dollars. This paper provides empirical data on these issues, using information included in the patents on drugs approved between 1988 and 2005. Overall, we find that direct government funding is more important in the development of "priority-review" drugs-sometimes described as the most innovative new drugs-than it is for "standard-review" drugs. Government funding has played an indirect role-for example, by funding basic underlying research that is built on in the drug discovery process-in almost half of the drugs approved and in almost two-thirds of priority-review drugs. Our analyses should help inform thinking about the returns on public research funding-a topic of long-standing interest to economists, policy makers, and health advocates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology
Powell, W. W., Koput, K. W., & Smith-Doerr, L. (1996) · Administrative Science Quarterly · doi:10.2307/2393988 · Cited by 8,499
Cited by
The high price of anticancer drugs: origins, implications, barriers, solutions
Prasad, V., De Jesús, K., & Mailankody, S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.31 · Cited by 442
Does Science Advance One Funeral at a Time?
Azoulay, P., Fons-Rosen, C., & Zivin, J. S. G. (2019) · American Economic Review · doi:10.1257/aer.20161574 · Cited by 371
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules
Azoulay, P., Graff Zivin, J. S., Li, D., & Sampat, B. N. (2019) · The Review of Economic Studies · doi:10.1093/restud/rdy034 · Cited by 349
Self-citationAddressing Dementia: The OECD Response
OECD (2015) · OECD Health Policy Studies · doi:10.1787/9789264231726-en · Cited by 327
Contribution of NIH funding to new drug approvals 2010–2016
Galkina Cleary, E., Beierlein, J. M., Khanuja, N. S., McNamee, L. M., & Ledley, F. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715368115 · Cited by 248
Metadata
- Authors
- Sampat, B. N., & Lichtenberg, F. R.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2011-02
- Volume
- 30
- Issue
- 2
- Pages
- 332-339
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2121280379
- Cited by
- 190
- References
- 1
- FWCI
- 24.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What Are The Respective Roles Of The Public And Private Sectors In Pharmaceutical Innovation? https://app.cochat.ai/papers/10.1377/hlthaff.2009.0917
- The paper
- Sampat, B. N., & Lichtenberg, F. R. (2011). What Are The Respective Roles Of The Public And Private Sectors In Pharmaceutical Innovation? Health Affairs. https://doi.org/10.1377/hlthaff.2009.0917
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.